G
GLP1 Lawsuit
Mass Tort Case Review
Call
GLP-1 Drug Injury

Tirzepatide Lawsuit (Mounjaro & Zepbound)

Tirzepatide is the active ingredient in both Mounjaro and Zepbound. Lawsuits allege Eli Lilly failed to adequately warn about serious gastrointestinal and other risks associated with the drug.

Call (717) 724-7503

Free Confidential Case Review

No fee unless you win. Takes under 60 seconds.

How tirzepatide works

Tirzepatide is a dual GLP-1 and GIP receptor agonist. It produces strong weight loss and glycemic control, but the same mechanisms that slow stomach emptying create the conditions for severe gastrointestinal injury in some patients.

Qualifying injuries

Gastroparesis, severe pancreatitis, intestinal obstruction or ileus, gallbladder disease requiring surgery, and aspiration during anesthesia are the principal injuries under investigation.

Frequently Asked Questions

Get your free, confidential case review

Takes under 60 seconds. No fee unless you win.

Free Confidential Case Review

No fee unless you win. Takes under 60 seconds.